United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 8, 2026 · Filed Jul 9, 2026

On Jul 8, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$553.17 for US$5.26M under a trading plan, leaving 40,513 shares. Filed Jul 9, 2026 (Form 4).

Sold
9,500 shares
Price
US$553.17 average (US$548.62 to US$560.79)
Value
US$5.26M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 8, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jul 8, 2026Common StockSale637US$548.6249,376Direct
Jul 8, 2026Common StockSale923US$549.5248,453Direct
Jul 8, 2026Common StockSale785US$550.4547,668Direct
Jul 8, 2026Common StockSale925US$551.5646,743Direct
Jul 8, 2026Common StockSale1,490US$552.5145,253Direct
Jul 8, 2026Common StockSale1,710US$553.4243,543Direct
Jul 8, 2026Common StockSale1,118US$554.4542,425Direct
Jul 8, 2026Common StockSale291US$555.7542,134Direct
Jul 8, 2026Common StockSale379US$556.6441,755Direct
Jul 8, 2026Common StockSale702US$557.8241,053Direct
Jul 8, 2026Common StockSale220US$558.7840,833Direct
Jul 8, 2026Common StockSale320US$560.7940,513Direct

Source

View original at SEC

Related